IH · iHuman Inc.
Market Cap
$63.89M
Shares
51.11M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.25
Open$1.38
Day$1.23–1.38
52W close$1.21–3.07
Avg vol 30d9K
Short int3K · 0.0% float · 1.1d
Short vol38%
Last earningsMar 31, 2021
DataOct 2020–Aug 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−30%
below
Price vs 50-day avg
−8%
below
RSI (14)
45
neutral
MACD trend
Positive
52-week position
2%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−7%
trailing
6-month return
−37%
trailing
YTD return
−40%
this year
Relative strength
−50%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+14% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.01% of float · ▼ -2.7% MoM · 1.1 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
8 holders — mid 3-yr range
Squeeze score
37
low risk · 0–100
Fundamentals
Revenue growth
−9%
Y/Y
Gross margin
68%
contracting
EPS growth
0%
Y/Y
Buyback
$10.0M
authorized
Quant / Vol
risk profile
Volatility
55%
annualized · 1-yr
Max drawdown
−60%
past year
ATR
6.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−30%
Bearish
Price vs 50-day avg
−8%
Bearish
RSI (14)
45
Neutral
MACD trend
Positive
Bullish
52-week position
2%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+14% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.01% of float · ▼ -2.7% MoM · 1.1 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
8 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $1 · 2%
Range high $3
vs 200-day avg -30%
vs 50-day avg -8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Education & Training Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IH
this stock
iHuman Inc.
|
$63.89M | -40.5% | -8.7% | — | 0.0% |
|
EDU
New Oriental Education & Technology Group Inc.
|
$9.26B | +6.9% | +13.6% | — | 1.9% |
|
TAL
TAL Education Group
|
$6.62B | +9.4% | +33.7% | — | 3.7% |
|
LAUR
Laureate Education, Inc.
|
$5.34B | +15.2% | +19.5% | 17.6 | 2.4% |
|
CVSA
Covista Inc.
|
$4.58B | +30.0% | +9.3% | 19.1 | 4.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
8
- % held
- 0.3%
- Net QoQ
- +20.5K sh
- Top holder
- MORGAN STANLEY
Held
Float
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IH | +1.6% | -7.4% | -36.6% | -7.4% | -40.5% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | +1.2% | -10.4% | -50.0% | -10.4% | -53.3% |
Capital returns
Latest dividend
$0.10
/ share · ex Apr 17, 2026
Paid (TTM)
$0.10
/ share · 1 payout
Dividend yield (TTM, derived)
— · history filling in
Buyback program
· as of Dec 31, 2021
Authorized
$10.00M
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.